|Complex Interventions Division
||Our work in Complex Interventions involves both definitive, large-scale, national, randomised controlled trials and earlier-phase research, including pilots, feasibility studies and intervention development; epidemiological studies and evidence synthesis; together with methodological research investigating real-world challenges of complex intervention evaluations.
|Early Phase Cancer Division
||Our work in Early Phase Cancer involves non-randomised and randomised controlled trials, which assess toxicity and tolerability and activity in interventions including chemotherapy, radiotherapy and biological agents. Our trials have innovative and novel methodologies which efficiently answer questions which provide evidence for interventions to be further evaluated or implemented.
|Late Phase Cancer Division
||Our work in Late Phase Cancer involves large randomised controlled trials, which compare two or more interventions including chemotherapy, radiotherapy or biological agents. Our trials have innovative designs which efficiently evaluate novel interventions and evaluate personalised medicine approaches.
|Leeds Unit for Complex Intervention Development (LUCID)
||LUCID is a methodological research group based across LIHS and LICTR within the School of Medicine, developing and optimising complex healthcare interventions to improve patient and public outcomes.
|Myeloma UK Concept and Access Research Programme
||In partnership with Myeloma UK, our research at the Leeds Myeloma UK CARP aims to delivery more trials, more quickly to patients with multiple myeloma and to focus on asking and answering the questions which matter most and bring earlier access to novel treatments for patients. We are the only clinical trials unit in the UK to carry out the full range of myeloma trials, from early to late phase giving more opportunities for patients to access new and innovative treatments and have a long history of successful collaborations with industry, academic institutions and charities.
|Surgical Interventions, Diagnostics and Devices
||Our portfolio of work in Surgical, Diagnostic and Device Interventions ranges from definitive, large-scale, international, randomised controlled trials to single-centre, earlier-phase research including feasibility and qualitative work; together with methodological research investigating real-world challenges of surgical and and device evaluations.
|The Leeds CRUK CTU based at Leeds CTRU
||Our research at the Leeds Cancer Research UK CTU aims to bring more opportunities for cancer patients to access new and innovative treatments. We are focussing on two groups of patients; those with cancers of the blood and those who are treated with radiotherapy. Our trials have innovative and designs which efficiently evaluate novel interventions and personalised medicine approaches.
|Yorkshire Cancer Research Early Phase Clinical Trials Centre
||The Yorkshire Cancer Research Early Phase Clinical Trials Centre is a Yorkshire-wide collaboration, coordinated by our team at Leeds Clinical Trials Research Unit, between clinical trialists encompassing statisticians, methodologists, laboratory scientists and clinicians.